AFYREN Doubles Revenue, Secures €15.5M in Financing as It Takes Full Control of Key Plant
Event summary
- AFYREN completed the €11.3M buyout of its NEOXY plant from SPI, gaining full ownership and control.
- Revenue doubled to €1.3M in H1 2026 compared to full-year 2025, with production surpassing 1,000 tonnes.
- Secured €12.5M in venture debt from BNP Paribas and a €3M grant from the European Just Transition Fund.
- Plant improvements in June 2026 pushed production capacity to 40% for 48 hours, targeting sustained efficiency.
- Net income turned positive at €2.4M for H1 2026, up from a €6.9M loss in H1 2025.
The big picture
AFYREN's full ownership of its NEOXY plant and strategic financing moves position it as a pure-play industrial greentech company. The buyout and improved production capacity come as global supply chains face disruptions, favoring local, circular, and decarbonized solutions. With secured market outlets and a push for premium pricing, AFYREN aims to leverage its first-mover advantage in bio-based carboxylic acids.
What we're watching
- Execution Risk
- Whether AFYREN can sustain and scale the 40% production capacity achieved in July 2026.
- Market Differentiation
- How AFYREN's certified, low-carbon, and bio-based positioning will compete against petrochemical alternatives.
- Expansion Strategy
- The pace at which AFYREN advances plans for Plant 2, targeting a 2030 commissioning.
Related topics